Basso Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Basso Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,153,853	Closed	-$11.7M	–	187
2018 Q3	$11.7M	Sell	1,153,853 -46,147	-4%	-$466K	2.59%	6
2018 Q2	$12M	Buy	1,200,000 +250,000	+26%	+$2.5M	2.29%	3
2018 Q1	$9.49M	Hold	950,000	–	–	1.75%	7
2017 Q4	$9.42M	Buy	950,000 +265,000	+39%	+$2.63M	1.54%	18
2017 Q3	$6.85M	Buy	685,000 +315,000	+85%	+$3.13M	0.85%	46
2017 Q2	$3.65M	Buy	370,000 +200,000	+118%	+$1.97M	0.48%	70
2017 Q1	$1.69M	Buy	+170,000	New	+$1.68M	0.25%	81

Basso Capital Management's ORGO Position: Q4 2018 in Review

Basso Capital Management sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 1,153,853 shares — an estimated $11.7M sold.

Basso Capital Management first reported a position in ORGO in Q1 2017 and held it in 7 quarters. The position peaked at $12M in Q2 2018. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

Basso Capital Management reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
Basso Capital Management sold 1,153,853 Organogenesis Holdings shares in Q4 2018, an estimated $11.7M.
Basso Capital Management first reported a position in Organogenesis Holdings in Q1 2017 and held it in 7 quarters.
Basso Capital Management's Organogenesis Holdings position peaked at $12M in Q2 2018.
0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on Basso Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.